GATA5 and lung carcinoma: GATA5 transcriptionally activated ARHGAP9, and restoration of ARHGAP9 expression significantly inhibited proliferation, migration, and invasion of lung-cancer cells, revealing the GATA5-ARHGAP9 axis as a potential therapeutic target [62].